Lancet 383 , 955962 (2014)
2008;135(6):205564, 64 e12
Video consultation Private and confidential Qualified TRT experts Your medication is dispensed by our GPhC-registered pharmacy and delivered to your home
Real-World Analysis (November 2025): A landmark study published in Science Daily (November 12, 2025) found that both semaglutide (Ozempic) and tirzepatide (Mounjaro) offer similar levels of heart protection , with only small differences in results
25 The bulk of the remaining 10% of the patients are diagnosed with type 1 diabetes (T1D), although other types exist that are rare
In recent cost of control analyses, once-weekly semaglutide 1 mg showed favourable cost-effectiveness compared with exenatide ER 2 mg and dulaglutide 1.5 mg in the USA and in Canada [27, 28], and compared with dulaglutide 1.5 mg, exenatide ER 2 mg, sitagliptin 100 mg and insulin glargine U100 in the UK [29]